{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,19]],"date-time":"2026-04-19T00:52:24Z","timestamp":1776559944050,"version":"3.51.2"},"reference-count":46,"publisher":"BMJ","issue":"11","license":[{"start":{"date-parts":[[2024,11,6]],"date-time":"2024-11-06T00:00:00Z","timestamp":1730851200000},"content-version":"unspecified","delay-in-days":5,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"name":"Simcere Pharma, Nanjing, China","award":["N\/A"],"award-info":[{"award-number":["N\/A"]}]},{"DOI":"10.13039\/501100001505","name":"Health Research Council of New Zealand","doi-asserted-by":"publisher","award":["19\/232"],"award-info":[{"award-number":["19\/232"]}],"id":[{"id":"10.13039\/501100001505","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Research and Development Program of China","award":["2022YFC2503300"],"award-info":[{"award-number":["2022YFC2503300"]}]},{"DOI":"10.13039\/501100001511","name":"Auckland Medical Research Foundation","doi-asserted-by":"publisher","award":["1318001"],"award-info":[{"award-number":["1318001"]}],"id":[{"id":"10.13039\/501100001511","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open"],"accepted":{"date-parts":[[2024,10,10]]},"published-print":{"date-parts":[[2024,11]]},"abstract":"<jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>The central biochemical cause of gout is hyperuricemia (elevated serum urate levels). Ultrasound features of monosodium urate (MSU) crystal deposition are common in people with asymptomatic hyperuricemia. However, it is unclear whether this is a precondition for the development of gout. This study aims to determine whether ultrasound imaging evidence of MSU crystal deposition predicts development of symptomatic gout over 5 years, in people who already have an increased risk of gout due to elevated serum urate concentrations (\u22658\u2009mg\/dL).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods and analysis<\/jats:title>\n                    <jats:p>This is a prospective, international, multicentre study. The study population comprises over 250 participants with asymptomatic hyperuricemia (serum urate \u22658.0\u2009mg\/dL). After the baseline assessments, participants are followed for 5 years or until the development of gout, defined by the 2015 American College of Rheumatology\/European Alliance of Associations for Rheumatology gout classification criteria. Baseline assessments include anthropomorphic measures, laboratory tests, questionnaires, blood and urine specimen collection, plain radiographs of the feet and standardised ultrasound scans of the lower limbs, scored according to the Outcomes in Rheumatology (OMERACT) gout ultrasound scoring system. The primary outcomes are the development of gout and time course for development of gout in people with and without ultrasound evidence of MSU crystal deposition. Exploratory analyses will examine clinical, genetic and biological factors associated with development of MSU crystal deposition and gout.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Ethics and dissemination<\/jats:title>\n                    <jats:p>This study protocol was approved by the New Zealand Ministry of Health Southern Health and Disability Ethics Committee (MEC\/05\/10\/130\/AM16) on 18 December 2018. The findings from this study will be published in peer-reviewed journals and will be presented at national and international conferences.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Trial registration number<\/jats:title>\n                    <jats:p>ACTRN12619000915156.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/bmjopen-2024-090415","type":"journal-article","created":{"date-parts":[[2024,11,7]],"date-time":"2024-11-07T12:21:14Z","timestamp":1730982074000},"page":"e090415","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":6,"title":["Development of gout in people with asymptomatic hyperuricemia: study protocol for a 5-year prospective cohort"],"prefix":"10.1136","volume":"14","author":[{"given":"Sarah","family":"Stewart","sequence":"first","affiliation":[{"name":"Faculty of Health and Environmental Sciences, Auckland University of Technology, Auckland, New Zealand"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Greg","family":"Gamble","sequence":"additional","affiliation":[{"name":"Department of Medicine, The University of Auckland Faculty of Medical and Health Sciences, Auckland, New Zealand"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William","family":"Taylor","sequence":"additional","affiliation":[{"name":"Rehabilitation Teaching & Research Unit, Department of Medicine, University of Otago Wellington, Wellington, New Zealand"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Isabel","family":"Su","sequence":"additional","affiliation":[{"name":"The University of Auckland Faculty of Medical and Health Sciences, Auckland, New Zealand"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tony","family":"Merriman","sequence":"additional","affiliation":[{"name":"School of Medical Sciences, University of Otago, Dunedin, New Zealand"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Borislav","family":"Mihov","sequence":"additional","affiliation":[{"name":"The University of Auckland Faculty of Medical and Health Sciences, Auckland, New Zealand"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anne","family":"Horne","sequence":"additional","affiliation":[{"name":"Department of Medicine, The University of Auckland Faculty of Medical and Health Sciences, Auckland, New Zealand"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0138-2912","authenticated-orcid":false,"given":"Lisa","family":"Stamp","sequence":"additional","affiliation":[{"name":"Department of Medicine, University of Otago Christchurch, Christchurch, New Zealand"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tristan","family":"Pascart","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, Lille Catholic University, Lille, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mariano","family":"Andr\u00e9s","sequence":"additional","affiliation":[{"name":"Alicante Institute for Health and Biomedical Research, Alicante, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria-Luisa","family":"Peral-Garrido","sequence":"additional","affiliation":[{"name":"Vinalop\u00f3 University Hospital, Elche, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tuhina","family":"Neogi","sequence":"additional","affiliation":[{"name":"Boston University School of Medicine, Boston, Massachusetts, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eleonora","family":"Norkuviene","sequence":"additional","affiliation":[{"name":"Lithuanian University of Health Sciences, Kaunas, Lithuania"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Janitzia","family":"Vazquez-Mellado","sequence":"additional","affiliation":[{"name":"General Hospital of Mexico, Ciudad de Mexico, Mexico"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John D","family":"FitzGerald","sequence":"additional","affiliation":[{"name":"Medicine, University of California Los Angeles David Geffen School of Medicine, Los Angeles, California, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lene","family":"Terslev","sequence":"additional","affiliation":[{"name":"Rigshospitalet, Kobenhavn, Denmark"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hilde Berner","family":"Hammer","sequence":"additional","affiliation":[{"name":"Diakonhjemmet Hospital, Oslo, Norway"},{"name":"University of Oslo, Oslo, Norway"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tillman","family":"Uhlig","sequence":"additional","affiliation":[{"name":"Universitetet i Oslo, Oslo, Norway"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria-Antonietta","family":"D\u2019Agostino","sequence":"additional","affiliation":[{"name":"Universit\u00e0 Cattolica del Sacro Cuore Facolt\u00e0 di Medicina e Chirurgia, Roma, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julia","family":"Martin","sequence":"additional","affiliation":[{"name":"Auckland District Health Board, Auckland, New Zealand"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mingshu","family":"Sun","sequence":"additional","affiliation":[{"name":"Qingdao University, Qingdao, Shandong, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Changgui","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Metabolism, The Affiliated Hospital of Qingdao University, Qingdao, Shandong, China"},{"name":"The Affiliated Hospital of Qingdao University, Qingdao, Shandong, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4632-4476","authenticated-orcid":false,"given":"Nicola","family":"Dalbeth","sequence":"additional","affiliation":[{"name":"The University of Auckland Faculty of Medical and Health Sciences, Auckland, New Zealand"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2024,11,7]]},"reference":[{"key":"2025121514363590000_14.11.e090415.1","doi-asserted-by":"publisher","DOI":"10.1002\/art.30520"},{"key":"2025121514363590000_14.11.e090415.2","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1177\/095952874803100109","article-title":"Observations on certain pathological conditions of the blood and urine, in gout, rheumatism, and Bright\u2019s disease","volume":"31","author":"Garrod","year":"1848","journal-title":"Med Chir Trans"},{"key":"2025121514363590000_14.11.e090415.3","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2017-212288"},{"key":"2025121514363590000_14.11.e090415.4","doi-asserted-by":"crossref","DOI":"10.1038\/srep19520","article-title":"Hyperuricemia and the risk for coronary heart disease morbidity and mortality a systematic review and dose-response meta-analysis","volume":"6","author":"Li","year":"2016","journal-title":"Sci Rep"},{"key":"2025121514363590000_14.11.e090415.5","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0114259","article-title":"Hyperuricemia and Risk of Incident Hypertension: A Systematic Review and Meta-Analysis of Observational Studies","volume":"9","author":"Wang","year":"2014","journal-title":"PLoS ONE"},{"key":"2025121514363590000_14.11.e090415.6","doi-asserted-by":"crossref","DOI":"10.1186\/1471-2369-15-122","article-title":"Is hyperuricemia an independent risk factor for new-onset chronic kidney disease?: A systematic review and meta-analysis based on observational cohort studies","volume":"15","author":"Li","year":"2014","journal-title":"BMC Nephrol"},{"key":"2025121514363590000_14.11.e090415.7","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1002\/acr.21772","article-title":"2012 American College of Rheumatology guidelines for management of gout. Part 1: systematic nonpharmacologic and pharmacologic therapeutic approaches to hyperuricemia","volume":"64","author":"Khanna","year":"2012","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"2025121514363590000_14.11.e090415.8","doi-asserted-by":"crossref","first-page":"86","DOI":"10.3390\/gucdd2020009","article-title":"Optimising the Use of Ultrasound in Gout: A Review from the Ground Up","volume":"2","author":"Filippucci","year":"2024","journal-title":"GUCDD"},{"key":"2025121514363590000_14.11.e090415.9","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kev112"},{"key":"2025121514363590000_14.11.e090415.10","doi-asserted-by":"publisher","DOI":"10.1016\/j.semarthrit.2006.08.001"},{"key":"2025121514363590000_14.11.e090415.11","doi-asserted-by":"crossref","first-page":"1847","DOI":"10.1002\/art.40572","article-title":"Brief Report: Monosodium Urate Monohydrate Crystal Deposits Are Common in Asymptomatic Sons of Patients With Gout: The Sons of Gout Study","volume":"70","author":"Abhishek","year":"2018","journal-title":"Arthritis Rheumatol"},{"key":"2025121514363590000_14.11.e090415.12","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2011.154997"},{"key":"2025121514363590000_14.11.e090415.13","doi-asserted-by":"crossref","first-page":"1814","DOI":"10.1002\/acr.23549","article-title":"Levels of Cytokines and Micro RNA s in Individuals With Asymptomatic Hyperuricemia and Ultrasonographic Findings of Gout: A Bench\u2010to\u2010Bedside Approach","volume":"70","author":"Estevez\u2010Garcia","year":"2018","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"2025121514363590000_14.11.e090415.14","first-page":"71","article-title":"Role of diagnostic ultrasonography in detecting gouty arthritis","volume":"35","author":"Gaber","year":"2013","journal-title":"The Egyp Rheum"},{"key":"2025121514363590000_14.11.e090415.15","doi-asserted-by":"crossref","DOI":"10.1186\/2193-1801-3-592","article-title":"Hidden gout- Ultrasound findings in patients with musculo-skeletal problems and hyperuricemia","volume":"3","author":"Reuss-Borst","year":"2014","journal-title":"Springerplus"},{"key":"2025121514363590000_14.11.e090415.16","doi-asserted-by":"crossref","DOI":"10.1186\/ar3223","article-title":"Joint and tendon subclinical involvement suggestive of gouty arthritis in asymptomatic hyperuricemia: an ultrasound controlled study","volume":"13","author":"Pineda","year":"2011","journal-title":"Arthritis Res Ther"},{"key":"2025121514363590000_14.11.e090415.17","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1002\/acr.20527","article-title":"Reproducibility of musculoskeletal ultrasound for determining monosodium urate deposition: concordance between readers","volume":"63","author":"Howard","year":"2011","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"2025121514363590000_14.11.e090415.18","doi-asserted-by":"publisher","DOI":"10.1080\/15257770802136040"},{"key":"2025121514363590000_14.11.e090415.19","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1002\/acr.23082","article-title":"Ultrasound Features of the First Metatarsophalangeal Joint in Gout and Asymptomatic Hyperuricemia: Comparison With Normouricemic Individuals","volume":"69","author":"Stewart","year":"2017","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"2025121514363590000_14.11.e090415.20","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1002\/art.39581","article-title":"Silent Monosodium Urate Crystal Deposits Are Associated With Severe Coronary Calcification in Asymptomatic Hyperuricemia: An Exploratory Study","volume":"68","author":"Andr\u00e9s","year":"2016","journal-title":"Arthritis Rheumatol"},{"key":"2025121514363590000_14.11.e090415.21","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/j.jdiacomp.2017.12.015","article-title":"Ultrasonographic assessment of joint pathology in type 2 diabetes and hyperuricemia: The Fremantle Diabetes Study Phase II","volume":"32","author":"Keen","year":"2018","journal-title":"J Diabetes Complicat"},{"key":"2025121514363590000_14.11.e090415.22","first-page":"264","article-title":"Articular cartilage of knee and first MTP joint are the preferred sites to find double contour sign as an evidence of urate crystal deposition in asymptomatic hyperuricemic individuals","volume":"43","author":"Bhadu","year":"2018","journal-title":"Acta Reumatol Port"},{"key":"2025121514363590000_14.11.e090415.23","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2014-205304"},{"key":"2025121514363590000_14.11.e090415.24","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2014-206397"},{"key":"2025121514363590000_14.11.e090415.25","doi-asserted-by":"publisher","DOI":"10.1002\/art.1780080214"},{"key":"2025121514363590000_14.11.e090415.26","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kev030"},{"key":"2025121514363590000_14.11.e090415.27","doi-asserted-by":"publisher","DOI":"10.1016\/j.berh.2007.06.002"},{"key":"2025121514363590000_14.11.e090415.28","unstructured":"EuroQol Group . EQ-5D: a standardised instrument for use as a measure of health outcomes. n.d. Available: https:\/\/euroqol.org\/"},{"key":"2025121514363590000_14.11.e090415.29","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1002\/acr.20570","article-title":"Illness perceptions in patients with gout and the relationship with progression of musculoskeletal disability","volume":"63","author":"Dalbeth","year":"2011","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"2025121514363590000_14.11.e090415.30","doi-asserted-by":"publisher","DOI":"10.1080\/08870449908407311"},{"key":"2025121514363590000_14.11.e090415.31","doi-asserted-by":"crossref","DOI":"10.1186\/1757-1146-6-44","article-title":"Inter and intra-rater repeatability of the scoring of foot pain drawings","volume":"6","author":"Chatterton","year":"2013","journal-title":"J Foot Ankle Res"},{"key":"2025121514363590000_14.11.e090415.32","doi-asserted-by":"publisher","DOI":"10.1016\/S0304-3959(99)00263-8"},{"key":"2025121514363590000_14.11.e090415.33","doi-asserted-by":"publisher","DOI":"10.1002\/art.20549"},{"key":"2025121514363590000_14.11.e090415.34","doi-asserted-by":"crossref","unstructured":"Major TJ , Takei R , Matsuo H , et al . A genome-wide association analysis of 2,622,830 individuals reveals new pathogenic pathways in gout. medRxiv [Preprint]. doi:10.1101\/2022.11.26.22281768","DOI":"10.1101\/2022.11.26.22281768"},{"key":"2025121514363590000_14.11.e090415.35","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1038\/nature04516","article-title":"Gout-associated uric acid crystals activate the NALP3 inflammasome","volume":"440","author":"Martinon","year":"2006","journal-title":"Nature New Biol"},{"key":"2025121514363590000_14.11.e090415.36","doi-asserted-by":"publisher","DOI":"10.1136\/ard.16.4.494"},{"key":"2025121514363590000_14.11.e090415.37","doi-asserted-by":"publisher","DOI":"10.1002\/art.22891"},{"key":"2025121514363590000_14.11.e090415.38","doi-asserted-by":"crossref","first-page":"2557","DOI":"10.1002\/art.39254","article-title":"2015 Gout Classification Criteria: an American College of Rheumatology\/European League Against Rheumatism collaborative initiative","volume":"67","author":"Neogi","year":"2015","journal-title":"Arthritis Rheumatol"},{"key":"2025121514363590000_14.11.e090415.39","doi-asserted-by":"publisher","DOI":"10.1007\/s10654-012-9668-8"},{"key":"2025121514363590000_14.11.e090415.40","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0263175","article-title":"Is repeat serum urate testing superior to a single test to predict incident gout over time?","volume":"17","author":"Stewart","year":"2022","journal-title":"PLoS One"},{"key":"2025121514363590000_14.11.e090415.41","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.semarthrit.2019.01.004","article-title":"Prevalence and discrimination of OMERACT-defined elementary ultrasound lesions of gout in people with asymptomatic hyperuricaemia: A systematic review and meta-analysis","volume":"49","author":"Stewart","year":"2019","journal-title":"Semin Arthritis Rheum"},{"key":"2025121514363590000_14.11.e090415.42","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.150366"},{"key":"2025121514363590000_14.11.e090415.43","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1016\/j.semarthrit.2020.11.011","article-title":"Consensus-based semi-quantitative ultrasound scoring system for gout lesions: Results of an OMERACT Delphi process and web-reliability exercise","volume":"51","author":"Christiansen","year":"2021","journal-title":"Semin Arthritis Rheum"},{"key":"2025121514363590000_14.11.e090415.44","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2015-207709"},{"key":"2025121514363590000_14.11.e090415.45","doi-asserted-by":"crossref","first-page":"4711","DOI":"10.1093\/rheumatology\/keac179","article-title":"Retrospective longitudinal assessment of ultrasound gout lesions using the OMERACT semi-quantitative scoring system","volume":"61","author":"Christiansen","year":"2022","journal-title":"Rheumatology (Oxford)"},{"key":"2025121514363590000_14.11.e090415.46","doi-asserted-by":"publisher","DOI":"10.2147\/PGPM.S105854"}],"container-title":["BMJ Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjopen-2024-090415","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,15]],"date-time":"2025-12-15T22:36:47Z","timestamp":1765838207000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjopen.bmj.com\/lookup\/doi\/10.1136\/bmjopen-2024-090415"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11]]},"references-count":46,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2024,11,7]]},"published-print":{"date-parts":[[2024,11]]}},"alternative-id":["10.1136\/bmjopen-2024-090415"],"URL":"https:\/\/doi.org\/10.1136\/bmjopen-2024-090415","relation":{},"ISSN":["2044-6055","2044-6055"],"issn-type":[{"value":"2044-6055","type":"print"},{"value":"2044-6055","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11]]}}}